Adage Capital Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,101,611
| Closed | -$11.7M | – | 1052 |
|
|
2022
Q2 | $11.7M | Buy |
+1,101,611
| New | +$11.7M | 0.03% | 634 |
|
|
2021
Q2 | – | Sell |
-1,800,000
| Closed | -$18.3M | – | 1019 |
|
|
2021
Q1 | $18.3M | Buy |
1,800,000
+200,000
| +13% | +$2.03M | 0.04% | 489 |
|
|
2020
Q4 | $11.9M | Buy |
+1,600,000
| New | +$11.9M | 0.03% | 548 |
|
|
2020
Q2 | – | Sell |
-7,500,000
| Closed | -$15M | – | 733 |
|
|
2020
Q1 | $15M | Buy |
7,500,000
+3,500,000
| +88% | +$7M | 0.04% | 386 |
|
|
2019
Q4 | $13.8M | Buy |
+4,000,000
| New | +$13.8M | 0.03% | 478 |
|